Gladstone Institutional Advisory’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.93M Buy
11,194
+1,421
+15% +$375K 0.08% 239
2026
Q2
$2.16M Buy
9,773
+63
+0.6% +$17.4K 0.07% 277
2026
Q1
$2.87M Buy
9,710
+403
+4% +$120K 0.11% 202
2025
Q4
$2.54M Buy
9,307
+1,878
+25% +$510K 0.1% 223
2025
Q3
$2.01M Buy
+7,429
New +$2.02M 0.08% 244
2024
Q1
– Sell
-3,945
Closed -$831K – 653
2023
Q4
$831K Buy
+3,945
New +$842K 0.05% 321
2023
Q3
– Sell
-1,387
Closed -$257K – 629
2023
Q2
$257K Sell
1,387
-3,013
-68% -$557K 0.02% 546
2023
Q1
$843K Sell
4,400
-9,013
-67% -$1.63M 0.05% 319
2022
Q4
$2.26M Buy
13,413
+2,796
+26% +$486K 0.16% 181
2022
Q3
$1.88M Buy
+10,617
New +$2.1M 0.15% 177

Other funds holding CME

Gladstone Institutional Advisory's CME Position: Q3 2026 in Review

Gladstone Institutional Advisory increased its CME Group (CME) stake by 15% in Q3 2026, buying an estimated $375K and bringing the position to 11,194 shares worth $2.93M. The position accounts for 0.08% of the portfolio, ranked #239.

Gladstone Institutional Advisory first reported a position in CME in Q3 2022 and has held it in 10 quarters since. 1,764 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Gladstone Institutional Advisory held 11,194 shares of CME Group worth $2.93M as of Q3 2026.
  • Gladstone Institutional Advisory bought 1,421 CME Group shares in Q3 2026, an estimated $375K.
  • CME Group made up 0.08% of Gladstone Institutional Advisory's portfolio in Q3 2026, its #239 holding.
  • Gladstone Institutional Advisory first reported a position in CME Group in Q3 2022 and has held it in 10 quarters since.
  • 1,764 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q3 2026, filed 13 Nov 2026.